Allergy Therapeutics
AGY.L
$0.16
Share price
1.45%
Change (1 day)
224.04%
Change (1 year)
Categories
Market capitalization of Allergy Therapeutics (AGY.L)
Market cap: NZ$0.75 Billion
As of March 2025 Allergy Therapeutics has a market cap of NZ$0.75 Billion. This makes Allergy Therapeutics the world's 7054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Allergy Therapeutics from 2004 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$0.75 B | 8.26% |
| 2024 | NZ$0.69 B | 191.1% |
| 2023 | NZ$0.24 B | 196.82% |
| 2022 | NZ$80.87 M | -80.23% |
| 2021 | NZ$0.40 B | 103.25% |
| 2020 | NZ$0.20 B | 58.51% |
| 2019 | NZ$0.12 B | -22.6% |
| 2018 | NZ$0.16 B | -49.09% |
| 2017 | NZ$0.32 B | 46.02% |
| 2016 | NZ$0.22 B | -41.13% |
| 2015 | NZ$0.37 B | 70.45% |
| 2014 | NZ$0.21 B | 234.13% |
| 2013 | NZ$65.81 M | -28.14% |
| 2012 | NZ$91.59 M | 44.39% |
| 2011 | NZ$63.43 M | 25.56% |
| 2010 | NZ$50.52 M | -47.52% |
| 2009 | NZ$96.26 M | 342.98% |
| 2008 | NZ$21.73 M | -73.78% |
| 2007 | NZ$82.89 M | -62.69% |
| 2006 | NZ$0.22 B | 81.66% |
| 2005 | NZ$0.12 B | -21.52% |
| 2004 | NZ$0.15 B |